Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapy

BACKGROUND: To test the hypothesis that point-of-care assays of platelet reactivity would demonstrate reduced response to antiplatelet therapy in patients who experienced Drug Eluting Stent (DES) ST whilst on dual antiplatelet therapy compared to matched DES controls. Whilst the aetiology of stent t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hobson, Alex R, Petley, Graham, Morton, Geraint, Dawkins, Keith D, Curzen, Nick P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Original Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268678/
https://www.ncbi.nlm.nih.gov/pubmed/18312665
http://dx.doi.org/10.1186/1477-9560-6-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268678/
https://www.ncbi.nlm.nih.gov/pubmed/18312665
http://dx.doi.org/10.1186/1477-9560-6-1

Ejemplares similares